Evaluation of a point-of-care immunoassay test kit `StrongStep' for cryptococcal antigen detection
Loading...
Files
Date
2018-01-05
Journal Title
Journal ISSN
Volume Title
Publisher
PLoS One
Abstract
HIV-associated cryptococcal meningitis is the leading cause of adult meningitis in Sub-Saharan Africa, accounting for 15%–20% of AIDS-attributable mortality. The development of point-of-care assays has greatly improved the screening and diagnosis of cryptococcal disease. We evaluated a point-of-care immunoassay, StrongStep (Liming Bio, Nanjing, Jiangsu, China) lateral flow assay (LFA), for cryptococcal antigen (CrAg) detection in cerebrospinal fluid (CSF) and plasma.
Description
Keywords
Citation
Mpoza, E., Mukaremera, L., Kundura, D. A., Akampurira, A., Luggya, T., Tadeo, K. K., ... & Abassi, M. (2018). Evaluation of a point-of-care immunoassay test kit ‘StrongStep’for cryptococcal antigen detection. PLoS One, 13(1), e0190652.